Jump to section
To achieve the lowest net healthcare cost through intelligent, real-time, automated technology.
Xevant was founded in order to streamline and automate age old inefficiencies within pharmaceutical analytics. The company’s data analytics and reporting platform revolutionises the traditional manual reporting software that slows down pharmaceutical testing and ultimately stalls new and vital drugs reaching the market.
Xevant builds complete analyses, reports and discovers client opportunities through automated processes, thus improving the accuracy of results and accelerating pharmaceutical progress. Recognised as America's Fastest Growing Private Software Company in 2022, the company’s fresh 2024 funding will be used to fuel its next phase of growth.
Freddie
Company Specialist at Welcome to the Jungle
Dec 2020
$3.2m
SEED
Brandon Newman
(CEO)Currently Founder at Xelero. Previously Co-Founder at ScripPoint, General Manager at CATAMARAN, CORP. and the Vice President of PREMATICS, LLC.